 |
 |

Dementia of Adult Polyglucosan Body DiseaseEvidence of Cortical and Subcortical Dysfunction
Ziad Rifai, MD;
Michael Klitzke, PhD;
Rabi Tawil, MD;
Ann Marie Kazee, MD;
Sara Shanske, PhD;
Salvatore DiMauro, MD;
Robert C. Griggs, MD
Arch Neurol. 1994;51(1):90-94.
Abstract
Objectives To characterize the dementia associated with adult polyglucosan body disease (APBD) and to correlate the cognitive deficits with abnormalities found on magnetic resonance imaging (MRI).
Methods Quantitative neuropsychological testing and MRI in one man with APBD and a review of the literature.
Results The dementia of APBD affects cortical and subcortical functions. The cognitive deficits correlate with MRI findings of cortical atrophy and white-matter abnormalities.
Conclusion Neuropsychological testing and MRI are helpful in the evaluation of patients with APBD.
Author Affiliations
From the Departments of Neurology (Drs Rifai, Tawil, and Griggs), Psychiatry (Dr Klitzke), and Pathology (Drs Kazee and Griggs), University of Rochester (NY), and the MDA H. Houston Merritt Clinical Research Center for Muscular Dystrophy, Columbia-Presbyterian Medical Center, New York, NY (Drs Shanske and DiMauro).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Adult Polyglucosan Body Disease Associated With Lewy Bodies and Tremor
Trivedi et al.
Arch Neurol 2003;60:764-766.
ABSTRACT
| FULL TEXT
Surprises of genetic engineering: A possible model of polyglucosan body disease
Raben et al.
Neurology 2001;56:1739-1745.
ABSTRACT
| FULL TEXT
|